TG Therapeutics, Inc. (LON:0VGI)
30.39
-6.72 (-18.11%)
Jan 9, 2026, 3:11 PM GMT
TG Therapeutics Employees
TG Therapeutics had 374 employees as of September 30, 2025. The number of employees increased by 55 or 17.24% compared to the same quarter last year.
Employees
374
Change
55
Growth
17.24%
Revenue / Employee
1.06M GBP
Profits / Employee
890.09K GBP
Market Cap
3.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 374 | 55 | 17.24% |
| Jun 30, 2025 | 370 | 70 | 23.33% |
| Mar 31, 2025 | 352 | 68 | 23.94% |
| Dec 31, 2024 | 338 | 74 | 28.03% |
| Sep 30, 2024 | 319 | 74 | 30.20% |
| Jun 30, 2024 | 300 | 56 | 22.95% |
| Mar 31, 2024 | 284 | 47 | 19.83% |
| Dec 31, 2023 | 264 | 38 | 16.81% |
| Sep 30, 2023 | 245 | 59 | 31.72% |
| Jun 30, 2023 | 244 | 71 | 41.04% |
| Mar 31, 2023 | 237 | 18 | 8.22% |
| Dec 31, 2022 | 226 | -60 | -20.98% |
| Sep 30, 2022 | 186 | -179 | -49.04% |
| Jun 30, 2022 | 173 | -155 | -47.26% |
| Mar 31, 2022 | 219 | -82 | -27.24% |
| Dec 31, 2021 | 286 | 14 | 5.15% |
| Sep 30, 2021 | 365 | 148 | 68.20% |
| Jun 30, 2021 | 328 | 152 | 86.36% |
| Mar 31, 2021 | 301 | 148 | 96.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
TG Therapeutics News
- 4 days ago - TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewsWire
- 6 days ago - TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum - GlobeNewsWire
- 9 days ago - Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - The Motley Fool
- 10 days ago - JP Morgan Adjusts Price Target for TGTX, Maintains Overweight Rating | TGTX Stock News - GuruFocus
- 23 days ago - TOTH FINANCIAL ADVISORY CORP Sells 100 Shares of TG Therapeutics Inc (TGTX) - GuruFocus
- 4 weeks ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 4 weeks ago - TG Therapeutics: The "Exit Velocity" You Can't Ignore (Rating Upgrade) - Seeking Alpha
- 4 weeks ago - Goldman Sachs Raises Price Target for TG Therapeutics (TGTX) to $39 | TGTX Stock News - GuruFocus